164 related articles for article (PubMed ID: 32615192)
1. Mechanisms of Exercise Limitation and Prevalence of Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis.
Heiden GI; Sobral JB; Freitas CSG; Pereira de Albuquerque AL; Salge JM; Kairalla RA; Fernandes CJCDS; Carvalho CRR; Souza R; Baldi BG
Chest; 2020 Dec; 158(6):2440-2448. PubMed ID: 32615192
[TBL] [Abstract][Full Text] [Related]
2. Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
Elbehairy AF; O'Donnell CD; Abd Elhameed A; Vincent SG; Milne KM; James MD; Webb KA; Neder JA; O'Donnell DE;
J Appl Physiol (1985); 2019 Oct; 127(4):1107-1116. PubMed ID: 31369329
[TBL] [Abstract][Full Text] [Related]
3. Physiologic Determinants of Exercise Capacity in Pulmonary Langerhans Cell Histiocytosis: A Multidimensional Analysis.
Rolland-Debord C; Fry S; Giovannelli J; Langlois C; Bricout N; Aguilaniu B; Bellocq A; Le Rouzic O; Dominique S; Delobbe A; François G; Tazi A; Wallaert B; Chenivesse C
PLoS One; 2017; 12(1):e0170035. PubMed ID: 28072848
[TBL] [Abstract][Full Text] [Related]
4. Exercise performance and dynamic hyperinflation in lymphangioleiomyomatosis.
Baldi BG; Albuquerque AL; Pimenta SP; Salge JM; Kairalla RA; Carvalho CR
Am J Respir Crit Care Med; 2012 Aug; 186(4):341-8. PubMed ID: 22700863
[TBL] [Abstract][Full Text] [Related]
5. Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?
Sobiecka M; Lewandowska K; Kober J; Franczuk M; Skoczylas A; Tomkowski W; Kuś J; Szturmowicz M
Lung; 2020 Jun; 198(3):547-554. PubMed ID: 32206858
[TBL] [Abstract][Full Text] [Related]
6. Effects of treatment with a combination of cardiac rehabilitation and bosentan in patients with pulmonary Langerhans cell histiocytosis associated with pulmonary hypertension.
Fukuda Y; Miura S; Fujimi K; Yano M; Nishikawa H; Yanagisawa J; Hiratsuka M; Shiraishi T; Iwasaki A; Saku K
Eur J Prev Cardiol; 2014 Dec; 21(12):1481-3. PubMed ID: 23897898
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies.
Le Pavec J; Lorillon G; Jaïs X; Tcherakian C; Feuillet S; Dorfmüller P; Simonneau G; Humbert M; Tazi A
Chest; 2012 Nov; 142(5):1150-1157. PubMed ID: 22459770
[TBL] [Abstract][Full Text] [Related]
8. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis.
Chaowalit N; Pellikka PA; Decker PA; Aubry MC; Krowka MJ; Ryu JH; Vassallo R
Mayo Clin Proc; 2004 Oct; 79(10):1269-75. PubMed ID: 15473409
[TBL] [Abstract][Full Text] [Related]
9. Severe pulmonary hypertension in histiocytosis X.
Fartoukh M; Humbert M; Capron F; Maître S; Parent F; Le Gall C; Sitbon O; Hervé P; Duroux P; Simonneau G
Am J Respir Crit Care Med; 2000 Jan; 161(1):216-23. PubMed ID: 10619823
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and survival following lung transplantation in patients with pulmonary Langerhans cell histiocytosis.
Wajda N; Zhu Z; Jandarov R; Dilling DF; Gupta N
Respirology; 2020 Jun; 25(6):644-650. PubMed ID: 31407478
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method.
Freitas CSG; Baldi BG; Jardim C; Araujo MS; Sobral JB; Heiden GI; Kairalla RA; Souza R; Carvalho CRR
Orphanet J Rare Dis; 2017 Apr; 12(1):74. PubMed ID: 28427470
[TBL] [Abstract][Full Text] [Related]
12. Cardiopulmonary exercise test and PaO
Skjørten I; Hilde JM; Melsom MN; Hisdal J; Hansteen V; Steine K; Humerfelt S
Int J Chron Obstruct Pulmon Dis; 2018; 13():91-100. PubMed ID: 29339921
[TBL] [Abstract][Full Text] [Related]
13. Phenotyping exercise limitation of patients with Interstitial Fibrosing Lung Disease: the importance of exercise hemodynamics.
Panagiotidou E; Βoutou A; Fouka E; Papakosta D; Chatzopoulos E; Sourla E; Markopoulou A; Kioumis I; Stanopoulos I; Pitsiou G
Pulmonology; 2024; 30(2):104-112. PubMed ID: 35568651
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Langerhans Cell Histiocytosis-associated Pulmonary Hypertension Showing a Drastic Improvement Following Smoking Cessation.
Kinoshita Y; Watanabe K; Sakamoto A; Hidaka K
Intern Med; 2016; 55(5):491-5. PubMed ID: 26935369
[TBL] [Abstract][Full Text] [Related]
15. The value of high-resolution computed tomography (HRCT) to determine exercise ventilatory inefficiency and dynamic hyperinflation in adult patients with cystic fibrosis.
Crisafulli E; Teopompi E; Luceri S; Longo F; Tzani P; Pagano P; Ielpo A; Longo C; Di Paolo M; Sverzellati N; Palange P; Chetta A; Pisi G
Respir Res; 2019 Apr; 20(1):78. PubMed ID: 31014329
[TBL] [Abstract][Full Text] [Related]
16. Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort.
Ribeiro Baptista B; d'Humières T; Schlemmer F; Bendib I; Justeau G; Al-Assaad L; Hachem M; Codiat R; Bardel B; Abou Chakra L; Belmondo T; Audureau E; Hue S; Mekontso-Dessap A; Derumeaux G; Boyer L
Respir Res; 2022 Mar; 23(1):68. PubMed ID: 35317815
[TBL] [Abstract][Full Text] [Related]
17. How I manage pulmonary Langerhans cell histiocytosis.
Lorillon G; Tazi A
Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28877978
[TBL] [Abstract][Full Text] [Related]
18. Diffusing capacity for carbon monoxide is linked to ventilatory demand in patients with chronic obstructive pulmonary disease.
Mahut B; Chevalier-Bidaud B; Plantier L; Essalhi M; Callens E; Graba S; Gillet-Juvin K; Valcke-Brossollet J; Delclaux C
COPD; 2012 Feb; 9(1):16-21. PubMed ID: 22292594
[TBL] [Abstract][Full Text] [Related]
19. Cardiopulmonary exercise testing and second-line pulmonary function tests to detect obstructive pattern in symptomatic smokers with borderline spirometry.
Di Marco F; Terraneo S; Job S; Rinaldo RF; Sferrazza Papa GF; Roggi MA; Santus P; Centanni S
Respir Med; 2017 Jun; 127():7-13. PubMed ID: 28502420
[TBL] [Abstract][Full Text] [Related]
20. Relationship between six-minute walking test and pulmonary function and ventilatory drive in patients with airflow limitation.
Chiang LL; Ho SC; Cheng HF; Sheng DF; Lin HC; Kuo HP
Chang Gung Med J; 2001 Mar; 24(3):159-66. PubMed ID: 11355083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
